FDA warns consumers of contaminated copycat eye drops

INDIANA- The FDA is warning consumers not to purchase or use South Moon, Rebright, or FivFivGo eye drops because of the potential risk of eye infection.

These are copycat eye drop products that consumers can easily mistake for Bausch + Lomb’s Lumify (brimonidine tartrate) brand eye drops, an over-the-counter product approved for redness relief.

South Moon, Rebright, and FivFivGo eye drops are unapproved drugs and should not be available in the U.S. They claim to treat eye conditions such as glaucoma, treated with prescription drugs or surgery.

Patients with signs or symptoms of an eye infection should talk to their healthcare provider or seek medical care immediately. FDA recommends consumers properly discard these products.

The FDA has not received any adverse event reports specifically naming the South Moon, Rebright or FivFivGo products. However, the agency has received reports on possibly fake Lumify, including product quality concerns, eye irritation, pain, and infection.

The agency recommends consumers only buy eye products from reputable retailers such as state-licensed pharmacies and beware of online retailers selling products with false claims.